Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
OrthopedicSpinal Implant

PUBLISHER: Grand View Research | PRODUCT CODE: 1404823

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1404823

Sacroiliac Joint Fusion Market Size, Share & Trends Analysis Report By Indication (Degenerative Sacroiliitis, Sacral Disruption), By Treatment Type (Surgery, Injections), By End-user, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 162 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Sacroiliac Joint Fusion Market Growth & Trends:

The global sacroiliac joint fusion market size is expected to reach USD 2.49 billion by 2030, according to a new report by Grand View Research, Inc.It is expected to expand at a CAGR of 19.8% from 2024 to 2030. Key market players are investing substantially in Research & Development (R&D) activities to create innovative and effective devices. This increase in R&D activities is expected to drive market growth over the coming years. In addition, the market is expected to grow further due to the increasing prevalence of bone disorders and ongoing technological advancements.

Increasing prevalence of lower back, buttock, groin, and lower extremity pain drives SI joint fusion market growth. These chronic and debilitating forms of pain have become alarmingly common, affecting a substantial portion of the global population. This trend poses significant challenges to healthcare systems and fuels demand for innovative solutions to alleviate suffering and restore mobility. Chronic pain in the lower back, buttock, groin, and lower extremity represents a significant portion of SI joint disorder cases, comprising 10% to 26% of such cases, as the Centers for Medicare & Medicaid Services reported in December 2021. The prevalence of symptoms associated with SI joint disorders highlights their substantial healthcare challenge.

In addition, a factor propelling market growth is the increasing use of innovative materials and technologies to develop improved and safer SI joint fusion systems. For instance, in October 2022, Aurora Spine, a company specializing in regenerative technologies focusing on minimally invasive approaches, announced that it had received 510(k) clearance from the U.S. FDA for its patented SiLO TFX MIS. The SI joint fixation system is a minimally invasive solution intended for SI joint fusion in cases involving SI joint disruptions and degenerative sacroiliitis. The SiLO TFX system comprises an ilium screw, sacrum screw, associated instrumentation, and transfixing cone designed to achieve fixation and stability for bony fusion between the sacrum and ilium. Thus, such technological advancements are expected to boost market growth.

North America dominated the market with the largest revenue share in 2023. North America is the leading market for upper limb prosthetics across the globe. The dominance can be attributed to advanced healthcare infrastructure, the presence of key companies, and growing reimbursement coverage. Key market players are involved in implementing strategic initiatives, such as conducting clinical tests of their products, regional expansion, patent applications, product launches, and partnerships & collaborations to increase their market share.

Sacroiliac Joint Fusion Market Report Highlights:

  • By indication, the degenerative sacroiliitis segment accounted for the largest revenue share of 38.6% in 2023. Growing awareness about the condition and improving diagnostic capabilities for sacroiliac joint disorders are among the major factors that drive the growth of the segment.
  • By treatment type, surgery segment dominated the market in terms of revenue share in 2023. Its dominance is attributed to the growing preference for minimally invasive surgeries, driven by their advantages, including smaller incisions, decreased pain & scarring, and quicker recovery periods.
  • By end user, the hospitals segment dominated the market in 2023. Hospitals offer specialized, extended care for patients, and their treatments are frequently eligible for reimbursement, further fostering their adoption.
  • North America dominated the market with the largest revenue share in 2023 owing to well-established healthcare infrastructure and increasing R&D investments by companies.
  • Asia Pacific region is expected to grow at the fastest rate during the forecast period, owing to the presence of a large patient pool, developing healthcare facilities, and investments by key companies in this region.
Show more
Product Code: GVR-4-68039-805-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Treatment
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Sacroiliac Joint Fusion Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of lower back, buttock, groin, and lower extremity pain
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Growing cases of Sacroiliitis or Sacroiliac joint dysfunction
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness
  • 3.3. Sacroiliac Joint Fusion Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Sacroiliac Joint Fusion Market: Indication Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Degenerative sacroiliitis
    • 4.1.2. Sacral disruption
    • 4.1.3. Trauma
  • 4.2. Indication Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Sacroiliac Joint Fusion Market by Indication Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Degenerative sacroiliitis
      • 4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Sacral disruption
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Trauma
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Sacroiliac Joint Fusion Market: Treatment Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Surgery
    • 5.1.2. Injections
    • 5.1.3. RF ablation
  • 5.2. Treatment Type Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Sacroiliac Joint Fusion Market by Treatment Type Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Surgery
      • 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Injections
      • 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. RF ablation
      • 5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Sacroiliac Joint Fusion Market: End User Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Ambulatory Surgical Centers
    • 6.1.3. Others
  • 6.2. End user Market Share, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Sacroiliac Joint Fusion Market by End User Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Hospitals
      • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 6.5.2. Ambulatory surgical centers
      • 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Others
      • 6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Sacroiliac Joint Fusion Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. SI-BONE, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. PainTEQ
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. CornerLoc
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. SIGNUS Medizintechnik GmbH
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Globus Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Orthofix Medical, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Life Spine, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Camber Spine Technologies, LLC
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. CoreLink Surgical
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Xtant Medical
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Surgalign Spine Technologies, Inc.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Medtronic
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives
Show more
Product Code: GVR-4-68039-805-9

List of Tables

  • 1. List of Abbreviation
  • 2. North America sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 3. North America sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 4. North America sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 5. North America sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 6. U.S. sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 7. U.S. sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 8. U.S. sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 9. Canada sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 10. Canada sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 11. Canada sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 12. Europe sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 13. Europe sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 14. Europe sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 15. Europe sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 16. Germany sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 17. Germany sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 18. Germany sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 19. UK sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 20. UK sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 21. UK sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 22. France sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 23. France sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 24. France sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 25. Italy sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 26. Italy sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 27. Italy sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 28. Spain sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 29. Spain sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 30. Spain sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 31. Denmark sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 32. Denmark sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 33. Denmark sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 34. Sweden sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 35. Sweden sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 36. Sweden sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 37. Norway sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 38. Norway sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 39. Norway sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 40. Asia Pacific sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 41. Asia Pacific sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 42. Asia Pacific sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 43. Asia Pacific sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 44. China sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 45. China sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 46. China sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 47. Japan sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 48. Japan sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 49. Japan sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 50. India sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 51. India sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 52. India sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 53. South Korea sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 54. South Korea sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 55. South Korea sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 56. Australia sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 57. Australia sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 58. Australia sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 59. Thailand sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 60. Thailand sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 61. Thailand sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 62. Latin America sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 63. Latin America sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 64. Latin America surgical ablation market, by treatment type, 2018 - 2030 (USD Million)
  • 65. Latin America laparoscopic ablation market, by end user, 2018 - 2030 (USD Million)
  • 66. Brazil sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 67. Brazil sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 68. Brazil sacroiliac joint market, by end user, 2018 - 2030 (USD Million)
  • 69. Mexico sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 70. Mexico sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 71. Mexico surgical ablation market, by end user, 2018 - 2030 (USD Million)
  • 72. Argentina sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 73. Argentina sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 74. Argentina surgical ablation market, by end user, 2018 - 2030 (USD Million)
  • 75. MEA sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 76. MEA sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 77. MEA sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 78. MEA sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 79. South Africa sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 80. South Africa sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 81. South Africa sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 82. Saudi Arabia sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 83. Saudi Arabia sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 84. Saudi Arabia sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 85. UAE sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 86. UAE sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 87. UAE sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 88. Kuwait sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 89. Kuwait sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 90. Kuwait sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)  

List of Figures

  • 1. Market research process
  • 2. Data triangulation techniques
  • 3. Primary research pattern
  • 4. Primary interviews in North America
  • 5. Primary interviews in Europe
  • 6. Primary interviews in APAC
  • 7. Primary interviews in Latin America
  • 8. Primary interviews in MEA
  • 9. Market research approaches
  • 10. Value-chain-based sizing & forecasting
  • 11. QFD modeling for market share assessment
  • 12. Market formulation & validation
  • 13. Sacroiliac joint fusion market: market outlook
  • 14. Sacroiliac joint fusion competitive insights
  • 15. Parent market outlook
  • 16. Related/ancillary market outlook
  • 17. Penetration and growth prospect mapping
  • 18. Industry value chain analysis
  • 19. Sacroiliac joint fusion market driver impact
  • 20 Sacroiliac joint fusion market restraint impact
  • 21. Sacroiliac joint fusion market strategic initiatives analysis
  • 22. Sacroiliac joint fusion market: Indication movement analysis
  • 23. Sacroiliac joint fusion market: Indication outlook and key takeaways
  • 24. Degenerative sacroiliitis market estimates and forecast, 2018 - 2030
  • 25. Sacral disruption market estimates and forecast, 2018 - 2030
  • 26. Trauma market estimates and forecast, 2018 - 2030
  • 27. Sacroiliac joint fusion market: Treatment Type Movement Analysis
  • 28. Sacroiliac joint fusion market: Treatment Type outlook and key takeaways
  • 29. Surgery market estimates and forecast, 2018 - 2030
  • 30. MIS market estimates and forecast,2018 - 2030
  • 31. Open market estimates and forecast, 2018 - 2030
  • 32. Dorsal & Anterior market estimates and forecast,2018 - 2030
  • 33 Lateral market estimates and forecast, 2018 - 2030
  • 34. Implants market estimates and forecast,2018 - 2030
  • 35. Accessories market estimates and forecast,2018 - 2030
  • 36. Injections market estimates and forecast,2018 - 2030
  • 37. Diagnosis market estimates and forecast,2018 - 2030
  • 38 Treatment market estimates and forecast,2018 - 2030
  • 39. RF ablation market estimates and forecast,2018 - 2030
  • 40 Sacroiliac joint fusion market: End User Movement Analysis
  • 41 Sacroiliac joint fusion market: End User outlook and key takeaways
  • 42 Hospitals market estimates and forecast, 2018 - 2030
  • 43 Ambulatory surgical centers market estimates and forecast,2018 - 2030
  • 44 Others market estimates and forecast, 2018 - 2030
  • 45 Global Sacroiliac joint fusion market: Regional movement analysis
  • 46 Global Sacroiliac joint fusion market: Regional outlook and key takeaways
  • 47 Global Sacroiliac joint fusion market share and leading players
  • 48 North America market share and leading players
  • 49 Europe market share and leading players
  • 50 Asia Pacific market share and leading players
  • 51. Latin America market share and leading players
  • 52. Middle East & Africa market share and leading players
  • 53. North America: SWOT
  • 54. Europe SWOT
  • 55. Asia Pacific SWOT
  • 56. Latin America SWOT
  • 57. MEA SWOT
  • 58. North America, by country
  • 59. North America
  • 60. North America market estimates and forecast, 2018 - 2030
  • 61. U.S.
  • 62. U.S. market estimates and forecast, 2018 - 2030
  • 63. Canada
  • 64. Canada market estimates and forecast, 2018 - 2030
  • 65. Europe
  • 66. Europe market estimates and forecast, 2018 - 2030
  • 67. UK
  • 68. UK market estimates and forecast, 2018 - 2030
  • 69. Germany
  • 70. Germany market estimates and forecast, 2018 - 2030
  • 71.. France
  • 72. France market estimates and forecast, 2018 - 2030
  • 73. Italy
  • 74. Italy market estimates and forecast, 2018 - 2030
  • 75. Spain
  • 76. Spain market estimates and forecast, 2018 - 2030
  • 77. Denmark
  • 78. Denmark market estimates and forecast, 2018 - 2030
  • 79. Sweden
  • 80. Sweden market estimates and forecast, 2018 - 2030
  • 81. Norway
  • 82. Norway market estimates and forecast, 2018 - 2030
  • 83. Asia Pacific
  • 84. Asia Pacific market estimates and forecast, 2018 - 2030
  • 85. China
  • 86. China market estimates and forecast, 2018 - 2030
  • 87. Japan
  • 88. Japan market estimates and forecast, 2018 - 2030
  • 89. India
  • 90. India market estimates and forecast, 2018 - 2030
  • 91. Thailand
  • 92. Thailand market estimates and forecast, 2018 - 2030
  • 93. South Korea
  • 94. South Korea market estimates and forecast, 2018 - 2030
  • 95. Australia
  • 96. Australia market estimates and forecast, 2018 - 2030
  • 97. Latin America
  • 98. Latin America market estimates and forecast, 2018 - 2030
  • 99. Brazil
  • 100. Brazil market estimates and forecast, 2018 - 2030
  • 101. Mexico
  • 102. Mexico market estimates and forecast, 2018 - 2030
  • 103. Argentina
  • 104. Argentina market estimates and forecast, 2018 - 2030
  • 105. Middle East and Africa
  • 106. Middle East and Africa market estimates and forecast, 2018 - 2030
  • 107. South Africa
  • 108. South Africa market estimates and forecast, 2018 - 2030
  • 109. Saudi Arabia
  • 110. Saudi Arabia market estimates and forecast, 2018 - 2030
  • 111. UAE
  • 112. UAE market estimates and forecast, 2018 - 2030
  • 113. Kuwait
  • 114. Kuwait market estimates and forecast, 2018 - 2030
  • 115. Market share of key market players- Sacroiliac joint fusion market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!